Erythromycin is used for: Susceptible infections; Respiratory tract infections; Enteritis; Pertussis; Trench fever; Chanroid; Chlamydial infections; Diphtheria; Legionnaire's disease; Pneumonia; Sinusitis; Bronchitis; Acne; Rheumatic fever; Neonatal conjunctivitis.
Recorded in the NepalDoc medicine catalog for Erythromycin.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets, USP and other antibacterial drugs, erythromycin tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.
From the U.S. FDA-approved label for Erythromycin. Full label: DailyMed.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin tablets, USP and other antibacterial drugs, erythromycin tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Erythromycin tablets, USP are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below: Upper respiratory tract infections of mild to moderate degree caused by Streptococcus pyogenes; Streptococcus pneumoniae; Haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of H. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved). (See appropriate sulfonamide labeling for prescribing information).
From the U.S. FDA-approved label for Erythromycin. Full label: DailyMed.
In most patients, erythromycin tablets are well absorbed and may be dosed orally without regard to meals. However, optimal blood levels are obtained when erythromycin tablets are given in the fasting state (at least 1/2 hour and preferably 2 hours before meals). Adults The usual dosage of Erythromycin Tablets is one 250 mg tablet four times daily in equally spaced doses or one 500 mg tablet every 12 hours.
Directions from the U.S. FDA-approved label for Erythromycin — your doctor or pharmacist may advise differently.
Erythromycin is contraindicated in patients with known hypersensitivity to this antibiotic. Erythromycin is contraindicated in patients taking terfenadine, astemizole, cisapride, pimozide, ergotamine or dihydroergotamine. (See PRECAUTIONS - Drug Interactions ). Do not use erythromycin concomitantly with HMG CoA reductase inhibitors (statins) that are extensively metabolized by CYP 3A4 (lovastatin or simvastatin), due to the increased risk of myopathy, including rhabdomyolysis.
Excerpt from the U.S. FDA-approved label for Erythromycin. Talk to a pharmacist or doctor before use.
Hepatotoxicity There have been reports of hepatic dysfunction, including increased liver enzymes and hepatocellular and/or cholestatic hepatitis, with or without jaundice, occurring in patients receiving oral erythromycin products. QT Prolongation Erythromycin has been associated with prolongation of the QT interval and infrequent cases of arrhythmia. Cases of torsades de pointes have been spontaneously reported during postmarketing surveillance in patients receiving erythromycin. Fatalities have been reported.
Warnings and precautions excerpt from the U.S. FDA-approved label for Erythromycin — not a complete list. Talk to a pharmacist or doctor before use.
The most frequent side effects of oral erythromycin preparations are gastrointestinal and are dose-related. They include nausea, vomiting, abdominal pain, diarrhea and anorexia. Symptoms of hepatitis, hepatic dysfunction and/or abnormal liver function test results may occur (See WARNINGS ). Onset of pseudomembranous colitis symptoms may occur during or after antibacterial treatment (See WARNINGS ).
Excerpt from the U.S. FDA-approved label for Erythromycin — not a complete list. Talk to a pharmacist or doctor about side effects.
18 brands · 6 makers in the NepalDoc catalog — see the full Erythromycin guide →
Storage Store at 20°C to 25°C (68°F to 77°F);
Storage information from the U.S. FDA-approved label for Erythromycin.
What is Eltocin 250?
Eltocin 250mg Tablet is a Erythromycin medicine made by Ipca Laboratories Ltd. It comes as 250mg Tablet.
What is Eltocin 250 used for?
Erythromycin is used for Susceptible infections, Respiratory tract infections, Enteritis, Pertussis, Trench fever, Chanroid, Chlamydial infections, Diphtheria, Legionnaire's disease, Pneumonia, Sinusitis, Bronchitis, Acne, Rheumatic fever, Neonatal conjunctivitis.
What is the generic name of Eltocin 250?
The generic name of Eltocin 250 is Erythromycin.
Which brands of Erythromycin are available in Nepal?
18 brands of Erythromycin are listed in the NepalDoc catalog, from 6 makers — including Althrocin 100mg Drop, Althrocin 125mg Syrup, Althrocin 250mg Tablet, Althrocin 500mg Tablet, Althrocin KID 125mg Tablet, E Cin Suspention.
What are the side effects of Erythromycin?
The most frequent side effects of oral erythromycin preparations are gastrointestinal and are dose-related. They include nausea, vomiting, abdominal pain, diarrhea and anorexia. Symptoms of hepatitis, hepatic dysfunction and/or abnormal liver function test results may occur (See WARNINGS ).
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
